Recruiting
GD2/CD70 Bi-specific CAR-T Cell Therapy
NCT05438368
- Conditions
- Cancer Disease, Neoplasms
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying Cancer Disease. Study availability and eligibility vary by location and protocol.
NCT05438368
NCT05437341